Gaetano M. Guglielmino
Equibles does not estimate personal net worth.
About Gaetano M. Guglielmino
Treace Medical Concepts, Inc. reported in an 8-K filed April 9, 2026 that Gaetano M. Guglielmino resigned as Chief Commercial Officer, effective April 8, 2026. The proxy statement of Treace Medical Concepts, Inc. reports total compensation of $468,536 for Gaetano M. Guglielmino in fiscal 2025, including a base salary of $440,000. Disclosed compensation is on record for 2 fiscal years.
“Effective as of the close of business on April 8, 2026, Gaetano M. Guglielmino, Chief Commercial Officer of Treace Medical Concepts, Inc. (the "Company"), will depart from the Company.”
Affiliation history
-
Treace Medical Concepts, Inc. (TMCI)
Proxy statement
Start not stated–2026-04-08
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Treace Medical Concepts, Inc. (TMCI) | Chief Commercial Officer | $440,000 | $468,536 |
| 2024 | Treace Medical Concepts, Inc. (TMCI) | Chief Commercial Officer | $37,268 | $3,230,098 |